Inventaire - your friends and communities are your best library - Inventaire

The aspirin in reducing events in the elderly trial: Statistical analysis plan.

author

Rory Wolfe

Jessica Lockery

Robyn L. Woods

Anne M. Murray

Mark Raymond Nelson

Christopher M Reid

Raj C. Shah

John J. McNeil

Michael E Ernst

published in: International Journal of Stroke

date of publication: 2017-11-07

main subject: aspirin, statistical analysis plan

Cites articles 10

Date

Title

Authors

2017-10-01

Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study

John J. McNeil, Rory Wolfe, Karen L. Margolis, Walter P Abhayaratna, Nigel Stocks, Sharyn Fitzgerald, Suzanne G Orchard, Ruth E. Trevaks, Brenda Kirpach
2013-10-07

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial
2009-05-30

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Rory Edwards Collins, Maria Carla Roncaglioni, Julie E. Buring, Charles H Hennekens, Richard Peto
2008-09-01

Using aspirin to prevent cognitive decline.

John W. Eikelboom, Martin O'Donnell
2007-05-12

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
2006-01

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis

Charles H Hennekens
2005-12-01

Low-dose aspirin for the prevention of atherothrombosis

Raffaele Landolfi
2005-06-04

Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged > or =70

Theo Vos, Danny Liew, Mark Raymond Nelson
1998-12-01

Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials
1976-01-01

A Measure of Primary Sociobiological Functions

Article - wd:Q47578953

Welcome to Inventaire

the library of your friends and communities

you are offline